Prevalence of hyperglycemia and its impact on mortality among HIV patients in Georgia

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Assessment of HCV screening and linkage to care modalities within the Georgia’s national Hepatitis C elimination program and designing the most optimal models for reaching the elimination targets

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Molecular epidemiology of Hepatitis C virus isolated from patients with newly diagnosed HCV infection in 2017-2021

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Surveillance of recent HIV infection in Georgia, 2018-2020

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

“ALT flare” implication into further TDF-containing chronic hepatitis B therapy effectiveness among people living with HIV

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

A series of cases of HIV and acute Hepatitis B coinfection – treatment issues

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Progress in roll-out of generic dolutegravir-based treatment in Georgia

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Avidity of antibodies to Hepatitis C virus in persons with newly diagnosed HCV infection

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Latvia on its’ way to achieve WHO plan to eliminate Hepatitis C by 2030

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Co-infections with Hepatitis virus B and C among patients with human immunodeficiency virus in a regional center of HIV/AIDS from northeastern Romania

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Hepatitis C virus treatment response to sofosbuvir/ledipasvir among adolescents coinfected with HIV and HCV: Real world data from Ukraine

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Associations between HLA Class II- DRB1 Alleles with susceptibility to Viral Hepatitis B and C in patients with HIV infection

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Occult HBV infection and two clinical cases with malignant comorbidities

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Randomized control trial of home-based Hepatitis C self-testing in key populations in Georgia

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Prevalence of Hepatitis among the general population in Botswana from the STI microbial survey of 2017/2018

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Simplified ART regime on the background of multi-allergy in an elderly HIV-infected patient

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Conference on Liver Disease in Africa (COLDA) 2022

Key Considerations for the Introduction of Hepatitis B Birth Dose Vaccine in Cameroon

Conference on Liver Disease in Africa (COLDA) 2021

A Community of Practice for the Introduction and Scale-up of Hepatitis B Birth Dose Vaccination in Africa: Challenges, Opportunities, and Lessons Learned

Conference on Liver Disease in Africa (COLDA) 2021

Hépatite Delta au Senegal

Conference on Liver Disease in Africa (COLDA) 2021

Long Term Follow up of Chronic Hepatitis B Cohort in Africa; The Prolifica Gambia Exprience

Conference on Liver Disease in Africa (COLDA) 2021

Assessment of Fibrosis Markers in HEPSANET: A Collaborative Network of Hepatitis B Cohorts in Sub-Saharan Africa

Conference on Liver Disease in Africa (COLDA) 2021

Age Cohort Screening for Hepatocellular Carcinoma in an African Population

Conference on Liver Disease in Africa (COLDA) 2021

Velpatasvir-Based Regimens in Treatment-Naïve and Treatment-Experienced Adults with Resistant Hepatitis C Virus Genotype 4 Subtypes Endemic to Sub-Saharan Africa: Findings from the SHARED-3 Study in Rwanda

Conference on Liver Disease in Africa (COLDA) 2021